Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin 17 mars 2022 Sani S., Pallaoro N., Messe M., Bernhard C., Etienne-Selloum N., Kessler H., Marinelli L., Entz-Werle N., Foppolo S., Martin S., Reita D., Dontenwill M. (2022). Cancers 4(2):369. DOI: 10.3390/cancers14020369.